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The genus Campylobacter includes slender spirally curved Gram-
negative rods. Campylobacter spp. are the etiologic agents of
worldwide zoonoses and are found in the gastrointestinal tracts
of many animals and in the environment, e.g. surface water.
Culture of Campylobacter necessitates specific conditions for
optimal recovery, i.e blood agar incubated in a microaerobic
atmosphere containing approximately 5% Oz, 10% COz and
85% N z for several days at 42°C. Among the four species of
clinical relevance, Campylobacter jejuni appears to be by far the
most important pathogen in humans. It is responsible for
diarrhea, sometimes associated with blood in stools, abdominal
pain, fever and occasionally vomiting. C. coli causes the same
disease but with a lower frequency. C. fetus subsp. fetus is known
to cause septicemia and focal infections in immunocompro-
mised patients. C. lari was first isolated from mammalian and
avian species, especially seagulls. In 1984, the first case ofhuman
disease related to C. lari was reported: fatal bacteremia in an
immunocompromised patient with multiple myeloma [1].
Since then, sporadic cases of enteric infection [2] as well as a
water-borne outbreak of C. larienteric infection [3] have been
reported. Bacteremia caused by C. lari is exceptional.
We report here a case of C. laribacteremia occurring in a 10-
year-old girl who underwent an occipital cavernoma excision.
The patient was admitted to the neurosurgery department
because of a post-radiotherapy occipital cavernoma. Her med-
ical story was marked by the discovery in 1993 of a large cell
anaplastic lymphoma, which was treated with chemotherapy
and cerebral radiotherapy. The child had been in remission since
1995. In 1999, she experienced occipital partial seizures. Radi-
ologic examinations led to the discovery of an occipital caver-
noma. She was treated with valproic acid, and an excision ofthe
cavernoma was performed. The patient received 0.25 mg of
tetracosactide (corticotropin), and antibiotic prophylaxis with
cloxacillin and amikacin in the immediate postoperative
period. On the following day, fever was noted without any
diarrhea or clinically evident infection. Hematological results
showed 15 X 109 leukocytes/L with 87% polymorphonuclear
neutrophils, and a C-reactive protein level of104 mg/L. One of
two blood cultures (Bactec plus Aerobic/F, Becton Dickinson,
Sparks Maryland, MD) was positive within 48 h for C. lari.
Subculture was possible within 24 h. The strain was sensitive to
amoxycillin/clavulanate, ticarcillin/clavulanate, gentamicin,
fosfomycin, ciprofloxacin, erythromycin and imipenem, but
was resistant to pefloxacin, sulfamethoxazole-trimethoprim,
piperacillin, piperacillin/tazobactam, amoxycillin, ticarcillin
and cephalosporins. Intravenous therapy with amoxicillin and
clavulanic acid was then begun in association with amikacin.
Evolution was favorable and marked by fever regression within
48 h. One stool culture, carried out several hours after the
beginning of therapy, was negative. There was no history of
exposure to animals or birds, or recent travel abroad.
C. lari infection is an infrequently detected event. In our
laboratory (Strasbourg University Hospital), from 1 January
1995 to 31 May 1999, 319 stool cultures were found to be
positive for Campylobacter spp. out of a total of 37, 432 stool
cultures performed during this period. Among these 319 stool
cultures, 292 were positive for C. jejuni (92%), 11 for C. coli
(3%), nine for C. lari (3%) and seven for Campylobacter spp. (2%)
(c. fetus is not searched for routinely in stools in our laboratory).
During the same period, 16 blood cultures were found to be
positive for Campylobacter spp.: 10 C. jejuni (63%), five C.fetus
(31%) and one C. lari (6%).
Bacteremia due to Campylobacter spp. remains infrequent. It
seems to be favored by older age, immunocompromised state
and serious underlying disease [4-6]. Our experience is in
accordance with this, as among the 16 patients with campylo-
bacter bacteremia, 11 were immunocompromised (one leuke-
mia, one lymphoma, two myeloma, one breast cancer, one
systemic lupus erythematosus, one rheumatoid arthritis, one
cirrhosis, one recent ischemic stroke, two serious postoperative
status), and 14 were over 40. Digestive symptoms may be absent
or mild.
To our knowledge, in addition to our patient, seven other
cases ofbacteremia due to C. larihave been published (Table 1).
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Table 1 Clinical characteristics of patients with C lari bacteremia
Case1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8
(1) (7) (4) (4) (8) (9) (10) This report
Sex M M NA NA Neonate M F F
Age 71years 22 years 25 days 42 years 83 years 10 years
Medical status Multiple myeloma AIDS Yes" Yes" None None Pacemaker Lymphoma
Chronic renal Coronary artery bypass Occipital cavernoma
failure Corticotropin
Digestive symptoms No Yes Yes No Yes Yes No No
C lari stool culture NA No NA NA Yes No No No
Antibiotherapy Vancomycin NA NA NA Erythromycin Erythromycin CiprofloxacinjVancomycin Arnoxicillin-clavulanic
Gentamicin Netilmicin Then acid Amikacin
Moxalactam lmipenern-qentamicin
Penicillin G Pacemaker removal
Evolution Death Death NA NA Good Good Good Good
"Underlvinq diseases mentioned by the authors without further description. ND, no data provided.
Four patients had an immunocompromised state: one patient
with myeloma [1], one patient with AIDS [7] and two patients
with underlying diseases not specified [4]. Two other cases
occurred in healthy patients in association with gastroenteritis: a
25-day-old neonate [8] and an adult [9]. The last case occurred
in a previously healthy woman who experienced recurrent C.
lari bacteremia with pacemaker infection [10]. A few case
reports of other extraintestinal infections due to C. lari, such
as urinary [11] or pleural [12] infections, have also been
described. We report here the eighth case of C. laribacteremia.
Invasion of blood from an intestinal focus has been suspected,
although the patient had no diarrhea before bacteremia. The
patient was not immunosuppressed, but she had undergone
surgical cavernoma excision and received a single dose of
corticotropin before the beginning of infection.
C. lari is infrequently found in humans but may occasionally
lead to intestinal disease and exceptionally to bacteremia,
particularly in immunocompromised patients.
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